Deep Health AI India Limited has issued a regulatory intimation to BSE Limited regarding an upcoming board meeting scheduled for Thursday, August 13, 2026. The meeting will be held at the company's registered office at 506-509 fifth floor, Apeksha, Plot No. 256, Main Road, Hiran Magri, Sector 11, Udaipur, Rajasthan (313001).
The primary agenda item for the board meeting is to consider and approve the Un-Audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.
In compliance with SEBI (Prohibition of Insider Trading) Regulation, 2015 and the Company's Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window for dealing in the company's shares has been closed for all Directors, Key Managerial Personnel (KMPs), Designated Employees, and Connected Persons since July 1, 2026. The trading window will remain closed until 48 hours after the declaration of the Un-Audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026 (both days inclusive).